IL6 and cancer: Specifically, IL-6 in the “inflammatory response” was upregulated in UC, which could enhance the proliferation of intestinal epithelial cells and increases their resistance to apoptosis in UC [6], meanwhile the proliferative and survival effects of IL-6 were mediated by STAT3 in colitis associated cancer [6].